DIAGNOSIS OF GASTRIC ADENOCARCINOMA USING A SCORING SYSTEM - COMBINED ASSAY OF SEROLOGICAL MARKERS OF HELICOBACTER-PYLORI INFECTION, PEPSINOGEN-I AND GASTRIN

被引:5
作者
LIN, JT
LEE, WC
WU, MS
WANG, JT
WANG, TH
CHEN, CJ
机构
[1] Department of Internal Medicine, College of Medicine and Institute of Public Health, College of Public Health, National Taiwan University, Taipei, 10017, No. 7
关键词
PEPSINOGEN I; HELICOBACTER-PYLORI; GASTRIC ADENOCARCINOMA; SCORING SYSTEM;
D O I
10.1007/BF02348659
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This study was carried out to develop a scoring system for the diagnosis of gastric adenocarcinoma (GAC). A total of 686 subjects, 150 patients with GAC, 182 with gastric ulcer, 127 with duodenal ulcer, and 227 subjects with negative findings, were enrolled. Analysis of the likelihood ratio (LR) showed that patients with advanced age, ulcer in the stomach, low serum levels of pepsinogen I (PGI), low PGI x gastrin values, and low PGI/gastrin ratio were likely to have GAC. Of these indicators, the serum PGI level had the greatest weight, with a LR of 7.59 for the group with a level <30 ng/ml. A scoring system combining serum PGI level, Helicobacter pylori seropositivity, and gastric ulcer status was derived, using a logistic regression model. This scoring system was found to be better than any one-parameter criterion for diagnosing GAC after evaluation by the area under the receiver operating characteristic curve (0.84; 95% confidence interval, 0.81-0.88) or by specificity-fixed sensitivity (sensitivity 0.82 at specificity 0.72, sensitivity 0.87 at specificity 0.66, sensitivity 0.96 at specificity 0.44). This scoring system may be potentially useful as a new model for the noninvasive diagnosis of GAC in the future.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 31 条
[1]  
Parkin D.M., Laara E., Muir C.S., Estimates of the worldwide frequency of sixteen major cancers in 1980, Int J Cancer, 41, pp. 184-197, (1988)
[2]  
Dupont J., Lee J., Burton G., Et al., Adenocarcinoma of the stomach: Review of 1497 cases, Cancer, 41, pp. 941-947, (1978)
[3]  
Ellis D.J., Speirs C., Kingston R.D., Et al., Carcinoembryonic antigen levels in advanced gastric carcinoma, Cancer, 42, pp. 623-625, (1978)
[4]  
Ritts R.E., Del Villano B.C., Go V.L.W., Et al., Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank, Int J Cancer, 33, pp. 339-345, (1984)
[5]  
Wobbes T., Thomas C., Segers M., Nagengast F., Evaluation of seven tumor markers (CA50, CA19-9, CA19-9 Truquant, CA72-4, CA195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma, Cancer, 69, pp. 2036-2041, (1992)
[6]  
Samloff I.M., Varis K., Ihamaki T., Et al., Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology: A study in relatives of patients with pernicious anemia, Gastroenterology, 83, pp. 204-209, (1982)
[7]  
Varis K., Samloff I.M., Ihamaki T., Siurala M., An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia, Dig Dis Sci, 24, pp. 187-191, (1979)
[8]  
Nomura A., Stemmerman G.N., Samloff I.M., Serum pepsinogen I as a predictor of stomach cancer, Ann Intern Med, 93, pp. 537-540, (1980)
[9]  
Stemmermann G.N., Samloff I.M., Nomura A., Heilbrun L.K., Serum pepsinogen I and II and stomach cancer, Clin Chim. Acta, 163, pp. 191-198, (1987)
[10]  
Sipponen P., Valle J., Varis K., Et al., Fasting levels of serum gastrin in different functional and morphological states of the antrofundal mucosa: An analysis of 860 subjects, Scand J Gastroenterol, 25, pp. 513-519, (1990)